Ectopic, constitutive expression of HESX1 and TLE3 in transgenic embryos affects gonadotroph and thyrotroph differentiation. Levels of transgene expression were examined in coronal sections of normal littermates and double-transgenic embryos at e18.5: Tg(Cga-Tle3), Tg(Cga-Hesx1). The first column (A, D, G, J, M, P, S, and V) display a representative nontransgenic littermate, whereas the second column (B, E, H, K, N, Q, T, and W) and the third column (C, F, I, L, O, R, U, and X) demonstrate two independent double-transgenic embryos designated as αTLE3, αHESX1. Mouse protamine 1 (Prm1) mRNA expression was used to select transgenics with robust expression levels for further analysis (A–C), whereas the expression of the individual transgene constructs was visualized by Hesx1 in situ hybridization (D–F) and TLE3 immunohistochemistry (G–I). The arrows in H and I depict the ectopic expression of TLE3 in the ventral portion of the pituitary gland. The differentiation of thyrotrophs and gonadotrophs was analyzed using immunohistochemistry with antibodies directed against TSHβ (J–L), LHβ (M–O), FSHβ (P–R), SF1 (S–U), and αGSU or CGA (V–X).